药品信息:
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(201411422252425.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- 部分中文索利塔-T1号输液处方资料(仅供参考)
治疗类名称
注入电解质溶液(起始溶液)
商标名称
索利塔-T1号输液(200毫升)
组成
这种药物包含下列组件。
在一个组件(200毫升)
氯化钠0.828克
L-乳酸钠0.448克
葡萄糖5.2克
一种添加剂(200毫升)中
L-乳酸(pH调节剂)
适量的热量
21kcal(200毫升中)
电解质浓度(毫当量/升)的
Na + 90
氯- 70
L-乳酸- 20
禁忌
很可能加剧患者乳酸血症[乳酸血。
效果或疗效
水,电解质未知的条件和脱水时的初始电源
供应水,电解质手术前后
静脉滴注成人一次500~1000毫升。如果300~500毫升每成人1小时
此外,根据年龄,病情,体重调整。
细心管理
存在引起基于肾脏疾病,或加重水电解质异常患者的肾功能衰竭的风险。
有心脏衰竭是由钠和[水心脏衰竭患者的负担加重的危险。
水和电解质异常,则有可能会导致血液中乳酸的上升,或加剧患者严重肝损伤。
有一种可能性,引起水,电解质异常,或加重患者尿量减少尿路梗阻。
甲升高的糖尿病患者的血糖水平,它是造成水,电解质异常,或恶化的风险。
Brand Name
Solita-T1 No. infusion (200mL)
Composition
This drug contains the following components.
One component (200mL) in
Sodium chloride 0.828 g
L-lactic acid sodium 0.448g
glucose 5.2g
One additive (200mL) in
L-lactic acid (pH modifier) appropriate amount
Amount of heat
21kcal (200mL in)
Electrolyte concentration (mEq / L)
Na + 90
Cl - 70
L-Lactate - 20
Contraindication
Is likely to exacerbate [lactic acid blood of patients lactic acid blood disease. ]
Effect or efficacy
Initial supply of water, electrolyte unknown at the time of the condition and dehydration
Supply of water, electrolyte before and after surgery
I intravenous infusion adult, once 500 ~ 1000mL. If 300 ~ 500mL 1 hour per adult, children.
Careful administration
There is a risk of causing the water-electrolyte abnormalities patients with renal failure based on renal disease, or exacerbation.
There is a risk of heart failure is exacerbated by the load of sodium and [Water patients with heart failure.
[Water and electrolyte abnormalities, there is a possibility to cause a rise in blood lactate, or exacerbate patients with severe liver damage. ]
There is a possibility to cause the water, electrolyte abnormalities, or exacerbate patients urine volume is reduced by obstructive uropathy. ]
A rise of the blood sugar levels of diabetic patients, the risk of it being cause water, electrolyte abnormalities, or exacerbated.
|